Jupiter Neurosciences, Inc.
JUNS
$5.24
-$0.76-12.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.70K | 21.80K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.70K | 21.80K | -- | -- | -- |
| Cost of Revenue | 415.40K | 47.90K | 816.70K | 759.40K | 466.70K |
| Gross Profit | -396.80K | -26.10K | -816.70K | -759.40K | -466.70K |
| SG&A Expenses | 1.57M | 2.78M | 1.48M | 1.51M | 1.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.98M | 2.83M | 2.30M | 2.26M | 1.54M |
| Operating Income | -1.96M | -2.81M | -2.30M | -2.26M | -1.54M |
| Income Before Tax | -2.06M | -2.58M | -2.29M | -2.25M | -1.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.06M | -2.58M | -2.29M | -2.25M | -1.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.06M | -2.58M | -2.29M | -2.25M | -1.53M |
| EBIT | -1.96M | -2.81M | -2.30M | -2.26M | -1.54M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 |
| EPS Diluted | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 35.26M | 38.18M | 34.04M | 33.18M | 33.10M |
| Average Diluted Shares Outstanding | 35.26M | 38.18M | 34.04M | 33.18M | 33.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |